Table 4.
Major risk factor | Global native T1 | Global ECV | ||
---|---|---|---|---|
r or rs | P value | r or rs | P-value | |
2014 ESC guidelines major risk factors | ||||
Maximal LVWT | 0.180 | 0.010* | 0.163 | 0.020* |
LA diameter | 0.202 | 0.004* | 0.219 | 0.002* |
LVOT gradient pressure | −0.002 | 0.980 | −0.151 | 0.032* |
SCD family history | 0.084 | 0.236 | 0.107 | 0.128 |
NSVT | 0.212 | 0.002* | 0.200 | 0.004* |
Unexplained syncope | −0.026 | 0.714 | 0.047 | 0.507 |
Age | 0.021 | 0.767 | −0.123 | 0.081 |
Enhanced ACC/AHA guidelines major risk factors | ||||
Maximal LVWT ≥30 mm | 0.147 | 0.037* | 0.205 | 0.003* |
LGE/LV mass ≥15% | 0.538 | <0.001* | 0.608 | <0.001* |
End-stage systolic dysfunction | 0.248 | <0.001* | 0.293 | <0.001* |
LV apical aneurysm | 0.051 | 0.466 | 0.135 | 0.055 |
ECV, extracellular volume fraction; r, Pearson correlation coefficient; rs, Spearman correlation coefficient; ESC, European Society of Cardiology; LVWT, left ventricular wall thickness; LV, left ventricular; LA, left atrium; LVOT, left ventricular outflow tract; SCD, sudden cardiac death; NSVT, non-sustained ventricular tachycardia; ACC/AHA, American College of Cardiology/American Heart Association; LGE, late gadolinium enhancement.
With statistically significant difference.